Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

CELL AND GENE THERAPY INSIGHTS

November 2020

Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

Download PDF

Foreword

Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

John Paul Tomtishen III

1 December 2020

Editorial

Process development: how to win the race in cell & gene therapy

Process development: how to win the race in cell & gene therapy

4 November 2020

Expert Insight

Measurement: the central nervous system of a quality manufacturing line for tissue engineering and regenerative medicine products

Measurement: the central nervous system of a quality manufacturing line for tissue engineering and regenerative medicine products

M Clare McCorry, R Robinson-Zeigler, R McFarland et al.

25 November 2020

The role of flow cytometry in advanced therapy medicinal products

The role of flow cytometry in advanced therapy medicinal products

Theo Nastos, PhD

20 November 2020

Limiting variability to achieve reproducibility in cell manufacturing

Limiting variability to achieve reproducibility in cell manufacturing

Anne Lamontagne, Andrew Fesnak

11 November 2020

Innovator Insight

De-risking the final formulation, fill and finish step in cell therapy manufacturing: considerations for an automated solution

De-risking the final formulation, fill and finish step in cell therapy manufacturing: considerations for an automated solution

Dalip Sethi, Annie Cunningham

26 November 2020

Expert Roundtable Video

Streamlining and optimizing viral vector bioprocess and analytical development

Streamlining and optimizing viral vector bioprocess and analytical development

J Tarnowski, N Kotsopoulou, K Patel et al.

22 December 2020

Expert Roundtable

Streamlining and optimizing viral vector bioprocess and analytical development

Streamlining and optimizing viral vector bioprocess and analytical development

19 January 2021

Methodology Paper

A cell therapy media fill protocol for validation of aseptic processing of cord blood

A cell therapy media fill protocol for validation of aseptic processing of cord blood

F DeDino, K Vincent, D DiNello et al.

24 November 2020

Interview

Addressing pain points in iPSC-derived cell therapy manufacture and scale-up

Addressing pain points in iPSC-derived cell therapy manufacture and scale-up

Bruno Marques, PhD

24 November 2020

Industrializing allogeneic cell therapy bioprocessing: devising streamlined solutions to complex challenges

Industrializing allogeneic cell therapy bioprocessing: devising streamlined solutions to complex challenges

23 November 2020

γδ T cell therapy: devising a manufacturing-friendly bioprocess

γδ T cell therapy: devising a manufacturing-friendly bioprocess

Dr Sean O’Farrell

17 November 2020

Challenges & trends in stem cell-derived extracellular vesicle bioprocessing

Challenges & trends in stem cell-derived extracellular vesicle bioprocessing

Jorge L Escobar Ivirico

12 November 2020

On Demand Webinar

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

Dr Sarah Snykers

Abbreviated in-house qualification of real time mycoplasma detection kit

Abbreviated in-house qualification of real time mycoplasma detection kit

Sowmya Viswanathan, PhD

Webinars on Demand: Expert Commentary

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

16 February 2021

Webinars

Focus on allogeneic CAR-Ts manufacturing challenges and solutions

Focus on allogeneic CAR-Ts manufacturing challenges and solutions

M Langtry, A Sargent, B Ahmadian Baghbaderani

5 November 2020

The right time to move to an automated manufacturing system like the Cocoon platform: the when, the why, and the how

The right time to move to an automated manufacturing system like the Cocoon platform: the when, the why, and the how

Matthew Hewitt, Donna Rill

3 December 2020